AlphaYouRT
Insider selling
Rahsaan Thompson sold $475K of Zevra Therapeutics, Inc. (ZVRA) stock
Rahsaan Thompson, Chief Legal & Compliance of Zevra Therapeutics, Inc. (ZVRA), sold 42,666 shares of ZVRA stock worth $475K, per an SEC Form 4 filed Aug 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 14, 2026, 3 days before it was made public.
ZVRA has moved +2.3% since the trade date, from $11.32 to $11.58 (Sep 22, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 17, 2026
- Filing delay
- 3 days
- Price since
- +2.3%
- Role
- Chief Legal & Compliance
- Source
- SEC Form 4
More ZVRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.